Next Article in Journal
Plate Fixation for Irreducible Proximal Humeral Fractures in Children and Adolescents—A Single-Center Case Series of Six Patients
Next Article in Special Issue
Comparison of the Standard vs. Thoracoscopic Extrapleural Modification of the Nuss Procedure—Two Centers’ Experiences
Previous Article in Journal
Long-Term Follow-Up of Renal Function in Children after Liver Transplantation—A Single Center Retrospective Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Independent Risk Factors for RBC Transfusion in Children Undergoing Surgery. Analysis of 14,248 Cases at a German University Hospital

1
Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University Frankfurt, 60590 Frankfurt, Germany
2
Department of Anaesthesia, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, 97080 Wuerzburg, Germany
3
Department of Paediatric Surgery and Paediatric Urology, University Hospital Frankfurt, Goethe University Frankfurt, 60590 Frankfurt, Germany
4
Department of Paediatric Intensive Care Medicine, Goethe University Frankfurt, 60590 Frankfurt, Germany
5
Institute of Biostatistics and Mathematical Modelling, Department of Medicine, Goethe University, 60590 Frankfurt, Germany
*
Author to whom correspondence should be addressed.
Submission received: 6 July 2021 / Revised: 22 July 2021 / Accepted: 22 July 2021 / Published: 25 July 2021

Abstract

:
Background: paediatric patients are vulnerable to blood loss and even a small loss of blood can be associated with severe shock. In emergency situations, a red blood cell (RBC) transfusion may become unavoidable, although it is associated with various risks. The aim of this trial was to identify independent risk factors for perioperative RBC transfusion in children undergoing surgery. Methods: to identify independent risk factors for perioperative RBC transfusion in children undergoing surgery and to access RBC transfusion rates and in-hospital outcomes (e.g., length of stay, mortality, and typical postoperative complication rates), a monocentric, retrospective, and observational study was conducted. Descriptive, univariate, and multivariate analyses were performed. Results: between 1 January 2010 and 31 December 2019, data from n = 14,248 cases were identified at the centre. Analysis revealed an RBC transfusion rate of 10.1% (n = 1439) in the entire cohort. The independent predictors of RBC transfusion were the presence of preoperative anaemia (p < 0.001; OR = 15.10 with preoperative anaemia and OR = 2.40 without preoperative anaemia), younger age (p < 0.001; ORs between 0.14 and 0.28 for children older than 0 years), female gender (p = 0.036; OR = 1.19 compared to male gender), certain types of surgery (e.g., neuro surgery (p < 0.001; OR = 10.14), vascular surgery (p < 0.001; OR = 9.93), cardiac surgery (p < 0.001; OR = 4.79), gynaecology (p = 0.014; OR = 3.64), visceral surgery (p < 0.001; OR = 2.48), and the presence of postoperative complications (e.g., sepsis (p < 0.001; OR = 10.16), respiratory dysfunction (p < 0.001; OR = 7.56), cardiovascular dysfunction (p < 0.001; OR = 4.68), neurological dysfunction (p = 0.029; OR = 1.77), and renal dysfunction (p < 0.001; OR = 16.17)). Conclusion: preoperative anaemia, younger age, female gender, certain types of surgery, and postoperative complications are independent predictors for RBC transfusion in children undergoing surgery. Future prospective studies are urgently required to identify, in detail, the potential risk factors and impact of RBC transfusion in children.

1. Introduction

Bleeding in children undergoing surgery, and the requirement for blood product transfusions, is a complex situation due to differences in blood volume and haemoglobin concentrations that are dependent on age and weight [1]. In general, paediatric patients are more vulnerable to blood loss because even a small loss can be associated with severe shock [1]. Further, particularly in children, transfusion of allogeneic blood products can be associated with various risks [2,3,4]. The risk of an adverse event after allogeneic blood transfusion is, in comparison to adults, 1.3 times higher in children over 1 year of age and 2.8 times higher in neonates [3,5]. Statistically, higher rates of allergic reactions, febrile non-haemolytic reactions, and acute haemolytic reactions are found more often in children than in adults [6]. Thus, a comprehensive risk-benefit assessment is required for any transfusion decision in children. Hence, in recent years, careful handling of perioperative blood products has become increasingly important. For the management of preoperative anaemia, restrictive transfusion strategies, and blood sparing techniques, a patient blood management (PBM) programme has evolved over the last decades [7,8]. Blood sparing techniques have always been the focus for paediatricians; however, studies dealing with this topic are rare. Although decreased transfusion rates for children in general and for those severely injured have been demonstrated, results for children undergoing surgery are scarce [9,10]. Currently, there are only a small number of studies in paediatric surgery that investigated transfusion strategies, such as from paediatric cardiac surgical patients [11].
Therefore, the goal of this trial was to identify independent risk factors for perioperative RBC transfusion in children undergoing surgery.

2. Materials and Methods

This study was approved by the Ethics Committee of the University Hospital Frankfurt, Goethe University (Ref: 19-338) and performed in accordance with the Declaration of Helsinki. The research was registered on ClinicalTrials.gov (NCT04349813) prior to data extraction and analysis.

2.1. Aim

The primary aim was to identify independent risk factors for perioperative RBC transfusion in children undergoing surgery. Secondary aims were the assessment of RBC transfusion rates and in-hospital outcomes (e.g., length of hospital stay, mortality, and typical postoperative complication rates).

2.2. Data Acquisition

In the German coding and billing system ‘Diagnosis-Related Groups (DRGs)’, surgeries and procedures are coded with a surgical or interventional procedural code (OPS), and diagnoses are coded with an international classification of disease (ICD) code, as reported previously [8,9].
Demographic (age and gender) and additional routine data (admission and discharge dates, discharge type, Hb value at admission and discharge, OPS and ICD codes, RBC, platelet, fresh frozen plasma (FFP), fibrinogen, and prothrombin complex concentrate (PCC) total consumption) from the hospital information system (ORBIS®, Agfa HealthCare, Bonn, Germany) were extracted, with help from the IT department, and consecutively validated by the statistician in charge.

2.3. Patient Inclusion and Exclusion Criteria

All non-adult (under 18 years of age) in-hospital patients with a defined gender (female or male) who underwent elective, urgent, and emergency surgery (OPS codes 5-01 to 5-99) between 1 January 2010 and 31 December 2019 at the University Hospital Frankfurt were included in the analysis (Figure 1). Open and laparoscopic procedures were included. No exclusion criteria were defined.

2.4. Statistics

The study was monocentric, retrospective, and observational. Different surgical specialities were assigned to surgery groups according to their specific OPS codes (Supplementary file Table S1). Information on complications was obtained from the ICD codes (Supplementary file Table S2), information on in-hospital mortality was acquired through the discharge codes, and information on hospital length of stay was obtained via the admission and discharge dates. Anaemia was defined by the Hb values, according to the definition of the World Health Organization (WHO): 12–59 months of age lower than 11.0 g/dL, 5–11 years of age: <11.5 g/dL, 12–14 years: <12.0 g/dL, female 15–17 years of age: <12.0 g/dL, and male 15–17 years of age <13.0 g/dL [12].
Results of the descriptive analysis of patient characteristics (age and gender), anaemia and clinical outcomes (length of stay, mortality, and postoperative complications) are presented as means (±standard error), medians (with IQR), and rates (with 95% CI). Univariate analysis (Chi-square tests for binary endpoints and Wilcoxon-Mann-Whitney tests for continuous endpoints) were used to evaluate the influence of individual factors (e.g., age, type of surgery, and preoperative anaemia) on several outcomes (e.g., mortality, length of stay, and complications). Finally, multivariate regression analysis was performed to evaluate potential independent influence factors on RBC transfusion rate and other typical outcomes, and the results related p-values and odds ratios (ORs) are shown. All analyses were performed using the software R (version 3.6.3) [13].

3. Results

3.1. Patients’ Characteristics

Between 1 January 2010 and 31 December 2019, data from n = 14,248 cases were identified at the centre. Overall, there were n = 8651 (60.7%) male and n = 5597 (39.3%) female children. The mean age was 6.3 (± 0.0) years. The detailed demographic data are depicted in Table 1.

3.2. RBC Transfusion

The analysis revealed an RBC transfusion rate of 10.1% (n = 1439) in the entire cohort. The median age was 2 years for transfused and 5 years for non-transfused children. A younger age was shown to be an independent predictor of RBC transfusion in the multivariate analysis, revealing that, for age groups older than 0 years of age, a significantly lower ratio of RBC transfused patients was predicted (p < 0.001 for all age groups, 1–4: OR = 0.28, 4–9: OR = 0.21, 10–14: OR = 0.18, and 15–17: OR = 0.14) (Table 2). RBC transfusion rates were the highest in the group of 0-year-old children (19.9%), whereas for the older children, the RBC transfusion rates were lower and comparable among each other (1–4: 7.4%, 4–9: 7.3%, 10–14: 8.8%, and 15–17: 7.7%).
Male children accounted for 55.9% of the transfused and for 61.3% of the non-transfused children. Descriptive analysis showed an RBC transfusion rate of 11.3% for the female gender and 9.3% for the male gender. Female gender was shown to be an independent predictor of RBC transfusion in the multivariate analysis (p = 0.036, OR = 1.19) (Table 2).
The type of surgery was shown to be an independent predictor for RBC transfusion in the multivariate analysis, comparing the influence of each surgery group with the influence of the reference group of dermatology and ophthalmology: neurosurgery (p < 0.001; OR = 10.14), vascular surgery (p < 0.001; OR = 9.93), cardiac surgery (p < 0.001; OR = 4.79), gynaecology (p = 0.014; OR = 3.64), and visceral surgery (p < 0.001; OR = 2.48) (Table 2). Transfusion rates were highest for children who underwent cardiac (39.7%), neurosurgical (26.4%), and vascular (25.5%) surgeries.
The preoperative anaemia rate was 82.4% in transfused children compared to an anaemia rate of 29.6% in non-transfused children (Table 3). Multivariate analysis revealed that preoperative anaemia was an independent predictor of RBC transfusion in children with preoperative anaemia (p < 0.001; OR = 15.10) and no preoperative anaemia (p < 0.001; OR = 2.40) (Table 2). Consequently, in the presence of preoperative anaemia, the transfusion rate was predicted to be approximately six-fold higher than without preoperative anaemia (Table 3). RBC transfusion rates were higher in the presence of preoperative anaemia as compared to the groups without (40.7% vs. 5.8%) and with unknown preoperative anaemia status (6.1%). As an additional analysis, RBC transfusion rates and corresponding preoperative Hb-values are shown in Figure 2. The results revealed that the lower the Hb value at admission, the higher the RBC transfusion rate.
Children who were transfused with RBC had a higher mortality rate (7.1% versus 0.1%) and a longer hospital LOS (median 32 versus 2 days, mean 42.0 vs. 4.4 days) than non-transfused children.
Complications occurred more frequently in children who were transfused than in children who were not transfused: sepsis/systemic inflammatory response syndrome (SIRS) (23.6 vs. 0.4%), respiratory (41.2% vs. 2.7%), cardiovascular (24.5% vs. 1.0%), neurological (4.8% vs. 0.5%), renal (11.7% vs. 0.1%), and hepatic dysfunction (0.6% vs. 0.0%), respectively (Table 4). Multivariate analysis demonstrated that sepsis/SIRS (p < 0.001; OR = 10.16), respiratory (p < 0.001; OR = 7.56), cardiovascular (p < 0.001; OR = 4.68), neurological (p = 0.029; OR = 1.77), and renal dysfunction (p < 0.001; OR = 16.17) were independent predictors for RBC transfusion (Table 2). RBC transfusion rates were higher in the presence of complications than without: sepsis/SIRS (88.3% vs. 7.9%), respiratory (63.4% vs. 6.4%), cardiovascular (72.8% vs. 7.9%), neurological (54.3% vs. 9.7%), renal (92.3% vs. 9.0%), and hepatic dysfunction (100.0% vs. 10.0%), respectively.

4. Discussion

In this study, we were able to show that 10.1% of children undergoing surgery required an RBC transfusion. Independent predictors of RBC transfusion were the presence of preoperative anaemia, younger age, female gender, certain types of surgery, sepsis, respiratory, cardiovascular, neurological, and renal dysfunction.
Preoperative anaemia is known to significantly impact RBC transfusion rate, mortality, and hospital LOS [14,15,16]. The results of our study also revealed, through multivariate analysis, that preoperative anaemia was an independent predictor of RBC transfusion, leading to approximately a six-fold higher transfusion rate. Thus, RBC transfusion rates were higher in the presence of preoperative anaemia than without (40.7% vs. 5.8%) and as compared to the group with unknown preoperative anaemia status (6.1%). This difference is, therefore, more evident than in the study of Faraoni et al., who investigated the influence of anaemia on the postoperative outcome in children undergoing surgery. The authors revealed that in children with and without anaemia, 12% and 11% were transfused, respectively [14]. In an analysis by Goobie et al., the influence of transfusion volumes on outcome was investigated [17]. In their multivariate analysis, age, gender, and type of surgery were found to be significant factors influencing RBC transfusion, as was also the case in our study [17]. Stey et al. revealed that young age (<2 years of age), high ASA classification IV, septic shock, and preoperative resuscitation were predictors for intra- and postoperative RBC transfusion [18]. Thus, as was found in our study, we were able to demonstrate younger age as a significant predictor for RBC transfusion.
What conclusions can be drawn from the results, and how can RBC transfusions be reduced to the absolute minimum? A central point here is the identification of anaemia and early therapy as a module of a PBM programme. Thus, the implementation of PBM programmes in paediatric institutions has increasingly been investigated [2,19,20,21]. Guidelines for the introduction of PBM programmes in children undergoing surgery are already available [1,22]. In addition to preoperative anaemia optimization, the question arises as to when a child should be transfused. It has to be clarified that there is limited evidence, rather than expert opinions [1], on the indication for transfusions in children as underlined by a recent review article [14]. However, guidelines do provide appropriate recommendations. The European Society of Anaesthesiology and Intensive Care (ESAIC) recommends a haemoglobin level in the range of 7.0 to 9.0 g/dL for bleeding children [23]. Liberal versus restrictive transfusion strategies in children have been compared in prospective randomized controlled trials in cardiac surgery and intensive care medicine [11,20]. The data indicate no differences in complications, clinical outcomes or mortality between the liberal (10.8 g/dL) and restrictive (8.0 g/dL) groups in children undergoing cardiac surgery [11]. A patient-individual indication for RBC transfusion is recommended. Individual transfusion triggers, such as pre-existing diseases and parameters for an insufficient oxygen supply or catecholamine requirement, should be considered.

Limitations

There are some study limitations. The analysis is retrospective by design and, therefore, the data are not completely tailored to all study aims. However, the data were queried and analysed according to standardized methods that were already used in other research projects conducted by our study group. On the basis of the database, no distinction could be made between emergency, urgent, or elective surgery. The data set did not allow for further differentiation of the surgery, surgical technique, and ASA status. Furthermore, in the context of PBM, unnecessary blood tests should be avoided and only performed in cases when indicated. Due to this issue, blood samples were not drawn in the majority of children prior to surgery. Hypothetically, children without preoperative blood sampling may be healthier and transfused in comparably low proportions compared to children without preoperative anaemia. However, a bias arises here: the exclusion of children without a known Hb value, as was implemented in other studies, may lead to a change in all other influencing parameters because only sicker children are supposedly included in the study. Prospective studies that include all required data in detail are, therefore, necessary to answer these questions. On the other hand, our study can provide useful indications to design future prospective studies and has the advantage of a high number of cases, which would not be feasible in prospective studies.

5. Conclusions

The present study demonstrates that preoperative anaemia, younger age, female gender, certain types of surgery, and postoperative complications are predictors for RBC transfusion in children undergoing surgery. Future prospective studies are urgently required to identify the potential risk factors and impact of RBC transfusion in children.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/children8080634/s1, Supplement I surgical specialties (OPS Codes) and Supplement II coding of the postoperative complications (ICD-Codes).

Author Contributions

Conceptualization, F.P., P.M., K.Z., and E.S.; data curation, E.S.; formal analysis, F.P. and E.S.; methodology, F.P., V.N., P.M., U.R., K.Z., and E.S.; project administration, F.P., P.M., and E.S.; software, E.S.; supervision, F.P., P.M., U.R., W.S., K.Z., and E.S.; validation, F.P., V.N., and E.S.; visualization, E.S.; writing—original draft, F.P. and E.S.; writing—review and editing, F.P., V.N., P.M., U.R., W.S., K.Z., and E.S. All authors have read and agreed to the published version of the manuscript.

Funding

This study was only supported by the Internal Institutional Research Funds from the Department of Anaesthesiology, Intensive Care and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.

Institutional Review Board Statement

This study was approved by the Ethics Committee of the University Hospital Frankfurt, Goethe University, Germany (Ref:19-338), and was performed in accordance with the Declaration of Helsinki.

Informed Consent Statement

The requirement for written informed consent by patients was waived by the Ethical Committee.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

F.P. received honoraria from Pharmacosmos for scientific lectures. P.M. and K.Z. received grants from B. Braun Melsungen, CSL Behring, Fresenius Kabi and Vifor Pharma for the implementation of Frankfurt‘s patient blood management program and honoraria for scientific lectures from B. Braun Melsungen, Vifor Pharma, Ferring, CSL Behring and Pharmacosmos.

References

  1. Goobie, S.M.; Gallagher, T.; Gross, I.; Shander, A. Society for the advancement of blood management administrative and clinical standards for patient blood management programs. 4th edition (pediatric version). Paediatr. Anaesth. 2019, 29, 231–236. [Google Scholar] [CrossRef]
  2. Parker, R.I. Transfusion in critically ill children: Indications, risks, and challenges. Crit. Care Med. 2014, 42, 675–690. [Google Scholar] [CrossRef] [PubMed]
  3. Lavoie, J. Blood transfusion risks and alternative strategies in pediatric patients. Paediatr. Anaesth. 2011, 21, 14–24. [Google Scholar] [CrossRef]
  4. Howard-Quijano, K.; Schwarzenberger, J.C.; Scovotti, J.C.; Alejos, A.; Ngo, J.; Gornbein, J.; Mahajan, A. Increased red blood cell transfusions are associated with worsening outcomes in pediatric heart transplant patients. Anesth. Analg. 2013, 116, 1295–1308. [Google Scholar] [CrossRef]
  5. Stainsby, D.; Jones, H.; Wells, A.W.; Gibson, B.; Cohen, H.; Group, S.S. Adverse outcomes of blood transfusion in children: Analysis of UK reports to the serious hazards of transfusion scheme 1996–2005. Br. J. Haematol. 2008, 141, 73–79. [Google Scholar] [CrossRef]
  6. Vossoughi, S.; Perez, G.; Whitaker, B.I.; Fung, M.K.; Stotler, B. Analysis of pediatric adverse reactions to transfusions. Transfusion 2018, 58, 60–69. [Google Scholar] [CrossRef]
  7. Althoff, F.C.; Neb, H.; Herrmann, E.; Trentino, K.M.; Vernich, L.; Fullenbach, C.; Freedman, J.; Waters, J.H.; Farmer, S.; Leahy, M.F.; et al. Multimodal Patient Blood Management Program Based on a Three-pillar Strategy: A Systematic Review and Meta-analysis. Ann. Surg. 2019, 269, 794–804. [Google Scholar] [CrossRef] [PubMed]
  8. Meybohm, P.; Herrmann, E.; Steinbicker, A.U.; Wittmann, M.; Gruenewald, M.; Fischer, D.; Baumgarten, G.; Renner, J.; Van Aken, H.K.; Weber, C.F.; et al. Patient Blood Management is Associated with a Substantial Reduction of Red Blood Cell Utilization and Safe for Patient’s Outcome: A Prospective, Multicenter Cohort Study with a Noninferiority Design. Ann. Surg. 2016, 264, 203–211. [Google Scholar] [CrossRef]
  9. Piekarski, F.; Steinbicker, A.; Zacharowski, K.; Meybohm, P. Changes in Transfusion Practice in Children and Adolescents over Time. Transfus. Med. Hemotherapy 2020, 47, 379–384. [Google Scholar] [CrossRef] [PubMed]
  10. Piekarski, F.; Kaufmann, J.; Engelhardt, T.; Raimann, F.J.; Lustenberger, T.; Marzi, I.; Lefering, R.; Zacharowski, K.; Meybohm, P.; TraumaRegister, D.G.U. Changes in transfusion and fluid therapy practices in severely injured children: An analysis of 5118 children from the TraumaRegister DGU(R). Eur. J. Trauma Emerg. Surg. 2020. [Google Scholar] [CrossRef]
  11. de Gast-Bakker, D.H.; de Wilde, R.B.; Hazekamp, M.G.; Sojak, V.; Zwaginga, J.J.; Wolterbeek, R.; de Jonge, E.; Gesink-van der Veer, B.J. Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: A randomized controlled trial. Intensive Care Med. 2013, 39, 2011–2019. [Google Scholar] [CrossRef] [PubMed]
  12. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity; World Health Organization: Geneva, Switzerland, 2011. [Google Scholar]
  13. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2017. Available online: https://www.R-project.org/ (accessed on 23 July 2021).
  14. Faraoni, D.; DiNardo, J.A.; Goobie, S.M. Relationship between Preoperative Anemia and In-Hospital Mortality in Children Undergoing Noncardiac Surgery. Anesth. Analg. 2016, 123, 1582–1587. [Google Scholar] [CrossRef] [PubMed]
  15. Goobie, S.M.; Faraoni, D.; Zurakowski, D.; DiNardo, J.A. Association of Preoperative Anemia with Postoperative Mortality in Neonates. JAMA Pediatrics 2016, 170, 855–862. [Google Scholar] [CrossRef] [PubMed]
  16. Dunne, J.R.; Malone, D.; Tracy, J.K.; Gannon, C.; Napolitano, L.M. Perioperative anemia: An independent risk factor for infection, mortality, and resource utilization in surgery. J. Surg. Res. 2002, 102, 237–244. [Google Scholar] [CrossRef]
  17. Goobie, S.M.; DiNardo, J.A.; Faraoni, D. Relationship between transfusion volume and outcomes in children undergoing noncardiac surgery. Transfusion 2016, 56, 2487–2494. [Google Scholar] [CrossRef]
  18. Stey, A.M.; Vinocur, C.D.; Moss, R.L.; Hall, B.L.; Cohen, M.E.; Kraemer, K.; Ko, C.Y.; Kenney, B.D. Variation in intraoperative and postoperative red blood cell transfusion in pediatric surgery. Transfusion 2016, 56, 666–672. [Google Scholar] [CrossRef] [PubMed]
  19. Istaphanous, G.K.; Wheeler, D.S.; Lisco, S.J.; Shander, A. Red blood cell transfusion in critically ill children: A narrative review. Pediatric Crit. Care Med. 2011, 12, 174–183. [Google Scholar] [CrossRef]
  20. Lacroix, J.; Hebert, P.C.; Hutchison, J.S.; Hume, H.A.; Tucci, M.; Ducruet, T.; Gauvin, F.; Collet, J.P.; Toledano, B.J.; Robillard, P.; et al. Transfusion strategies for patients in pediatric intensive care units. N. Engl. J. Med. 2007, 356, 1609–1619. [Google Scholar] [CrossRef] [Green Version]
  21. Perez-Ferrer, A.; Gredilla-Diaz, E.; de Vicente-Sanchez, J.; Sanchez Perez-Grueso, F.; Gilsanz-Rodriguez, F. Implementation of a patient blood management program in pediatric scoliosis surgery. Rev. Esp. Anestesiol. Reanim. 2016, 63, 69–77. [Google Scholar] [CrossRef] [PubMed]
  22. Faraoni, D.; Meier, J.; New, H.V.; Van der Linden, P.J.; Hunt, B.J. Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines. J. Cardiothorac. Vasc. Anesth. 2019, 33, 3249–3263. [Google Scholar] [CrossRef]
  23. Kozek-Langenecker, S.A.; Ahmed, A.B.; Afshari, A.; Albaladejo, P.; Aldecoa, C.; Barauskas, G.; De Robertis, E.; Faraoni, D.; Filipescu, D.C.; Fries, D.; et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology: First update 2016. Eur. J. Anaesthesiol. 2017, 34, 332–395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Flowchart of patient selection process.
Figure 1. Flowchart of patient selection process.
Children 08 00634 g001
Figure 2. Proportion of patients transfused according to haemoglobin threshold. RBC transfusion rate (%) dependence on Hb value at admission (g/dL).
Figure 2. Proportion of patients transfused according to haemoglobin threshold. RBC transfusion rate (%) dependence on Hb value at admission (g/dL).
Children 08 00634 g002
Table 1. Patient characteristics and type of surgery.
Table 1. Patient characteristics and type of surgery.
RBC-Transfusion n (%)
1439 (10.1%)
Non-RBC-Transfusion n (%)
12,809 (89.9%)
p-Value
Patient characteristics
Gender male55.9% (53.3–58.5%); n = 80561.3% (60.4–62.1%); n = 7846<0.001
Age (years)4.9 (±0.1), 2.0 (0.0; 9.0)6.4 (±0.0), 5.0 (1.0; 11.0)<0.001
Proportion of Age groups <0.001
038.6%; n = 55517.5%; n = 2240
1–421.3%; n = 30729.9%; n = 3829
5–915.3%; n = 22021.8%; n = 2796
10–1415.0%; n = 21617.5%; n = 2242
15–179.8%; n = 14113.3%; n = 1702
Type of surgery
Proportion of surgery groups <0.001
Dermatology, Ophthalmology3.4%; n = 4912.2%; n = 1567
Neurosurgery10.0%; n = 1443.1%; n = 401
Otorhinolaryngology1.3%; n = 1932.0%; n = 4096
Thoracic surgery 0.7%; n = 100.4%; n = 55
Cardiac surgery2.0%; n = 290.3%; n = 44
Vascular surgery16.5%; n = 2385.4%; n = 697
Visceral and endocrine surgery18.7%; n = 26912.7%; n = 1621
Urology1.0%; n = 156.2%; n = 796
Gynaecology 0.3%; n = 50.7%; n = 84
Obstetric0.1%; n = 10.4%; n = 52
Oral-maxillofacial surgery0.0%; n = 01.4%; n = 178
Trauma and orthopaedic surgery1.3%; n = 1811.0%; n = 1403
Haematopoietic and lymphatic system 18.8%; n = 2711.5%; n = 194
Mixed group25.8%; n = 37112.7%; n = 1621
Table 2. Predictors for RBC transfusion.
Table 2. Predictors for RBC transfusion.
Risk FactorUnivariate AnalysisMultivariate Analysis
p-Valuep-Value; OR (with 95% CI)
Gender<0.001p = 0.036; OR = 1.19 (1.01–1.39)
(female compared to male)
Age (years)
0
1–4
5–9
10–14
15–17
<0.001
(all compared to age 0)
p < 0.001; OR = 0.28 (0.20–0.38)
p < 0.001; OR = 0.21 (0.15–0.30)
p < 0.001; OR = 0.18 (0.13–0.26)
p < 0.001; OR = 0.14 (0.10–0.21)
Anaemia at admission
Anaemia
No anaemia
Unknown 1
<0.001
p < 0.001; OR = 15.10 (11.58–19.90)
p < 0.001; OR = 2.40 (1.76–3.30)
(all compared to unknown)
Type of surgery
Dermatology, Ophthalmology
Neurosurgery
Otorhinolaryngology
Thoracic surgery
Cardiac surgery
Vascular surgery
Visceral and endocrine surgery
Urology
Gynaecology
Obstetric
Oral-maxillofacial surgery
Trauma and orthopaedic surgery
Haematopoietic and lymphatic system
Mixed group
<0.001(all compared to Derm. and Oph.)
p < 0.001; OR = 10.14 (6.48–16.19)
p < 0.001; OR = 0.29 (0.15–0.53)
p = 0.598; OR = 1.31 (0.46–3.36)
p < 0.001; OR = 4.79 (2.05–11.04)
p < 0.001; OR = 9.93 (6.48–15.59)
p < 0.001; OR = 2.48 (1.64–3.83)
p = 0.676; OR = 1.17 (0.55–2.35)
p = 0.014; OR = 3.64 (1.16–9.51)
p = 0.559; OR = 0.55 (0.03–2.71)
p = 0.963; OR = 0.00 (0.00–0.00)
p = 0.669; OR = 1.15 (0.60–2.13)
p < 0.001; OR = 36.98 (23.51–59.41)
p < 0.001; OR = 5.86 (3.91–8.99)
Sepsis/SIRS 2<0.001p < 0.001; OR = 10.16 (6.98–15.07)
Respiratory dysfunction<0.001p < 0.001; OR = 7.56 (6.01–9.52)
Cardiovascular dysfunction<0.001p < 0.001; OR = 4.68 (3.43–6.40)
Neurological dysfunction<0.001p = 0.029, OR = 1.77 (1.06–2.97)
Renal dysfunction<0.001p < 0.001; OR = 16.17 (8.33–33.55)
Hepatic dysfunction<0.001p = 0.988; OR = 5.58 × 106 (0.00–∞) 3
1 Blood sampling at admission is not a routine part of surgical care for children, unless it is necessary due to the disease severity. 2 Systemic inflammatory response syndrome. 3 Upper CI endless, due to non-transfusion for hepatic dysfunction (0.0% (0.0–0.0%); n = 0 non-transfused versus 0.6% (0.2–1.1%); n = 8 transfused.
Table 3. Haemoglobin values and transfusion rate.
Table 3. Haemoglobin values and transfusion rate.
Hb Values and Transfusion RatesRBC-Transfusion n (%)
1439 (10.1%)
Non-RBC-Transfusion n (%)
12,809 (89.9%)
p-Value
Hb value at admission (g/dL) 10.9 (±0.1), 10.3 (8.4; 12.7)12.6 (±0.0), 12.5 (11.1; 13.7)<0.001
Anaemia rate at admission 82.4% (79.6–85.0%); n = 66129.6% (28.0–31.2%); n = 963<0.001
Proportion of anaemia groups at admission <0.001
Anaemia at admission (%)45.9%; n = 6617.5%; n = 963
No anaemia at admission (%)9.8%; n = 14117.9%; n = 2291
Unknown anaemia status at admission 144.3%; n = 63774.6%; n = 9555
Hb value at discharge (g/dL) 10.1 (±0.1), 9.8 (8.7; 11.3)12.3 (±0.0), 12.3 (11.2; 13.3)<0.001
Anaemia rate at discharge 87.9% (85.4–90.1%); n = 711 25.6% (24.4–26.8%); n = 1393 <0.001
Proportion of anaemia groups at discharge <0.001
Anaemia at discharge49.4%; n = 71110.9%; n = 1393
No anaemia at discharge6.8%; n = 9831.6%; n = 4052
Unknown anaemia status at discharge43.8%; n = 63057.5%; n = 7364
Platelet transfusion rate47.9% (45.3–50.6%); n = 690 0.7% (0.5–0.8%); n = 87 <0.001
FFP 2 transfusion rate30.6% (28.2–33.0%); n = 440 0.4% (0.3–0.5%); n = 45<0.001
Fibrinogen transfusion rate3.3% (2.4–4.3%); n = 47 0.0% (0.0–0.1%); n = 5 <0.001
PCC 3 transfusion rate3.3% (2.4–4.3%); n = 470.1% (0.1–0.2%); n = 19<0.001
1 Blood sampling at admission is not a routine part of surgical care for children, unless it is necessary due to the disease severity. 2 FFP: fresh frozen plasma. 3 PCC: prothrombin complex concentrate.
Table 4. Complications.
Table 4. Complications.
ComplicationsRBC-Transfusion n (%)
1439 (10.1%)
Non-RBC-Transfusion n (%)
12,809 (89.9%)
p-Value
Sepsis/SIRS 123.6% (21.4–25.8%); n = 3390.4% (0.3–0.5%); n = 45<0.001
Respiratory dysfunction41.2% (38.7–43.8%); n = 5932.7% (2.4–3.0%); n = 342<0.001
Cardiovascular dysfunction24.5% (22.3–26.8%); n = 3531.0% (0.9–1.2%); n = 132<0.001
Neurological dysfunction4.8% (3.7–6.0%); n = 690.5% (0.3–0.6%); n = 58<0.001
Renal dysfunction11.7% (10.1–13.4%); n = 1680.1% (0.1–0.2%); n = 14<0.001
Hepatic dysfunction0.6% (0.2–1.1%); n = 80.0% (0.0–0.0%); n = 0<0.001
Mortality7.1% (5.8–8.5%); n = 1020.1% (0.0–0.1%); n = 9<0.001
Hospital LOS 2 (days)42.0 (± 1.1), 32.0 (13.0; 53.0)4.4 (± 0.1), 2.0 (1.0; 4.0)<0.001
1 Systemic inflammatory response syndrome. 2 LOS: length of stay.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Piekarski, F.; Neef, V.; Meybohm, P.; Rolle, U.; Schneider, W.; Zacharowski, K.; Schmitt, E. Independent Risk Factors for RBC Transfusion in Children Undergoing Surgery. Analysis of 14,248 Cases at a German University Hospital. Children 2021, 8, 634. https://0-doi-org.brum.beds.ac.uk/10.3390/children8080634

AMA Style

Piekarski F, Neef V, Meybohm P, Rolle U, Schneider W, Zacharowski K, Schmitt E. Independent Risk Factors for RBC Transfusion in Children Undergoing Surgery. Analysis of 14,248 Cases at a German University Hospital. Children. 2021; 8(8):634. https://0-doi-org.brum.beds.ac.uk/10.3390/children8080634

Chicago/Turabian Style

Piekarski, Florian, Vanessa Neef, Patrick Meybohm, Udo Rolle, Wilfried Schneider, Kai Zacharowski, and Elke Schmitt. 2021. "Independent Risk Factors for RBC Transfusion in Children Undergoing Surgery. Analysis of 14,248 Cases at a German University Hospital" Children 8, no. 8: 634. https://0-doi-org.brum.beds.ac.uk/10.3390/children8080634

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop